CovidFranceV1, Main, Exploration, bibRecord, 000401

The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.

Identifieur interne : 000401 ( Main/Exploration ); précédent : 000400; suivant : 000402

The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.

Auteurs : Katie Palmer [Italie] ; Alessandro Monaco [France] ; Miia Kivipelto [Suède, Finlande, Royaume-Uni] ; Graziano Onder [Italie] ; Stefania Maggi [Italie] ; Jean-Pierre Michel [Suisse] ; Rita Prieto [Espagne] ; Georgia Sykara [Grèce] ; Shaantanu Donde [Royaume-Uni]

Source :

Aging clinical and experimental research [ 1720-8319 ] ; 2020.

RBID : pubmed:32458356

Descripteurs français

English descriptors

KwdEn :
- Aged (MeSH), Betacoronavirus (MeSH), Chronic Disease (epidemiology), Coronavirus Infections (complications), Coronavirus Infections (mortality), Coronavirus Infections (prevention & control), Delivery of Health Care (MeSH), Disease Outbreaks (MeSH), Disease Progression (MeSH), Europe (epidemiology), Frail Elderly (psychology), Frailty (complications), Frailty (psychology), Healthy Aging (MeSH), Humans (MeSH), Infection Control (MeSH), Loneliness (MeSH), Noncommunicable Diseases (epidemiology), Pandemics (prevention & control), Pneumonia, Viral (complications), Pneumonia, Viral (mortality), Pneumonia, Viral (prevention & control), Prevalence (MeSH), Quarantine (MeSH).
MESH :
- geographic , epidemiology : Europe.
- complications : Coronavirus Infections, Frailty, Pneumonia, Viral.
- epidemiology : Chronic Disease, Noncommunicable Diseases.
- mortality : Coronavirus Infections, Pneumonia, Viral.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- psychology : Frail Elderly, Frailty.
- Aged, Betacoronavirus, Delivery of Health Care, Disease Outbreaks, Disease Progression, Healthy Aging, Humans, Infection Control, Loneliness, Prevalence, Quarantine.

Abstract

The early stages of the COVID-19 pandemic have focused on containing SARS-CoV-2 infection and identifying treatment strategies. While controlling this communicable disease is of utmost importance, the long-term effect on individuals with non-communicable diseases (NCD) is significant. Although certain NCDs appear to increase the severity of COVID-19 and mortality risk, SARS-CoV-2 infection in survivors with NCDs may also affect the progression of their pre-existing clinical conditions. Infection containment measures will have substantial short- and long-term consequences; social distancing and quarantine restrictions will reduce physical activity and increase other unhealthy lifestyles, thus increasing NCD risk factors and worsening clinical symptoms. Vitamin D levels might decrease and there might be a rise in mental health disorders. Many countries have made changes to routine management of NCD patients, e.g., cancelling non-urgent outpatient visits, which will have important implications for NCD management, diagnosis of new-onset NCDs, medication adherence, and NCD progression. We may have opportunities to learn from this unprecedented crisis on how to leverage healthcare technologies and improve procedures to optimize healthcare service provision. This article discusses how the COVID-19 outbreak and related infection control measures could hit the most frail individuals, worsening the condition of NCD patients, while further jeopardizing the sustainability of the healthcare systems. We suggest ways to define an integrated strategy that could involve both public institutional entities and the private sector to safeguard frail individuals and mitigate the impact of the outbreak.

DOI: 10.1007/s40520-020-01601-4
PubMed: 32458356
PubMed Central: PMC7248450

Affiliations:

Espagne, Finlande, France, Grèce, Italie, Royaume-Uni, Suisse, Suède
Angleterre, Attique (région), Canton de Genève, Communauté de Madrid, Grand Londres, Latium, Svealand, Île-de-France
Athènes, Genève, Londres, Madrid, Paris, Rome, Stockholm
Université de Genève

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001091
to stream Main, to step Curation: 001091

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.</title>
<author><name sortKey="Palmer, Katie" sort="Palmer, Katie" uniqKey="Palmer K" first="Katie" last="Palmer">Katie Palmer</name>
<affiliation wicri:level="3"><nlm:affiliation>Oliba, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Oliba, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Catholic University of the Sacred Heart, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Catholic University of the Sacred Heart, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Monaco, Alessandro" sort="Monaco, Alessandro" uniqKey="Monaco A" first="Alessandro" last="Monaco">Alessandro Monaco</name>
<affiliation wicri:level="3"><nlm:affiliation>HEC, 1, Rue de la Liberation Jouy en Josas, Paris, France. alessandro.monaco@hec.edu.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>HEC, 1, Rue de la Liberation Jouy en Josas, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kivipelto, Miia" sort="Kivipelto, Miia" uniqKey="Kivipelto M" first="Miia" last="Kivipelto">Miia Kivipelto</name>
<affiliation wicri:level="3"><nlm:affiliation>Division of Clinical Geriatrics, Department of NVS, Center for Alzheimer Research, Karolinska Institutet, Karolinska University Hospital, Theme Aging, Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Clinical Geriatrics, Department of NVS, Center for Alzheimer Research, Karolinska Institutet, Karolinska University Hospital, Theme Aging, Stockholm</wicri:regionArea>
<placeName><settlement type="city">Stockholm</settlement>
<region nuts="2">Svealand</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio</wicri:regionArea>
<wicri:noRegion>Kuopio</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Ageing and Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Ageing and Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Onder, Graziano" sort="Onder, Graziano" uniqKey="Onder G" first="Graziano" last="Onder">Graziano Onder</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maggi, Stefania" sort="Maggi, Stefania" uniqKey="Maggi S" first="Stefania" last="Maggi">Stefania Maggi</name>
<affiliation wicri:level="1"><nlm:affiliation>CNR-Neuroscience Institute, Aging Branch, Padua, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>CNR-Neuroscience Institute, Aging Branch, Padua</wicri:regionArea>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Michel, Jean Pierre" sort="Michel, Jean Pierre" uniqKey="Michel J" first="Jean-Pierre" last="Michel">Jean-Pierre Michel</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Geriatrics and Rehabilitation, Medical University of Geneva, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Geriatrics and Rehabilitation, Medical University of Geneva, Geneva</wicri:regionArea>
<orgName type="university">Université de Genève</orgName>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Prieto, Rita" sort="Prieto, Rita" uniqKey="Prieto R" first="Rita" last="Prieto">Rita Prieto</name>
<affiliation wicri:level="3"><nlm:affiliation>Pfizer GEP SLU, Upjohn, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Pfizer GEP SLU, Upjohn, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sykara, Georgia" sort="Sykara, Georgia" uniqKey="Sykara G" first="Georgia" last="Sykara">Georgia Sykara</name>
<affiliation wicri:level="3"><nlm:affiliation>Medical Affairs, Upjohn Hellas Ltd (Division of Pfizer), Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Medical Affairs, Upjohn Hellas Ltd (Division of Pfizer), Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Donde, Shaantanu" sort="Donde, Shaantanu" uniqKey="Donde S" first="Shaantanu" last="Donde">Shaantanu Donde</name>
<affiliation wicri:level="1"><nlm:affiliation>Upjohn (Division of Pfizer), Surrey, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Upjohn (Division of Pfizer), Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32458356</idno>
<idno type="pmid">32458356</idno>
<idno type="doi">10.1007/s40520-020-01601-4</idno>
<idno type="pmc">PMC7248450</idno>
<idno type="wicri:Area/Main/Corpus">001091</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001091</idno>
<idno type="wicri:Area/Main/Curation">001091</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001091</idno>
<idno type="wicri:Area/Main/Exploration">001091</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.</title>
<author><name sortKey="Palmer, Katie" sort="Palmer, Katie" uniqKey="Palmer K" first="Katie" last="Palmer">Katie Palmer</name>
<affiliation wicri:level="3"><nlm:affiliation>Oliba, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Oliba, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Catholic University of the Sacred Heart, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Catholic University of the Sacred Heart, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Monaco, Alessandro" sort="Monaco, Alessandro" uniqKey="Monaco A" first="Alessandro" last="Monaco">Alessandro Monaco</name>
<affiliation wicri:level="3"><nlm:affiliation>HEC, 1, Rue de la Liberation Jouy en Josas, Paris, France. alessandro.monaco@hec.edu.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>HEC, 1, Rue de la Liberation Jouy en Josas, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kivipelto, Miia" sort="Kivipelto, Miia" uniqKey="Kivipelto M" first="Miia" last="Kivipelto">Miia Kivipelto</name>
<affiliation wicri:level="3"><nlm:affiliation>Division of Clinical Geriatrics, Department of NVS, Center for Alzheimer Research, Karolinska Institutet, Karolinska University Hospital, Theme Aging, Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Clinical Geriatrics, Department of NVS, Center for Alzheimer Research, Karolinska Institutet, Karolinska University Hospital, Theme Aging, Stockholm</wicri:regionArea>
<placeName><settlement type="city">Stockholm</settlement>
<region nuts="2">Svealand</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio</wicri:regionArea>
<wicri:noRegion>Kuopio</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Ageing and Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Ageing and Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Onder, Graziano" sort="Onder, Graziano" uniqKey="Onder G" first="Graziano" last="Onder">Graziano Onder</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Maggi, Stefania" sort="Maggi, Stefania" uniqKey="Maggi S" first="Stefania" last="Maggi">Stefania Maggi</name>
<affiliation wicri:level="1"><nlm:affiliation>CNR-Neuroscience Institute, Aging Branch, Padua, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>CNR-Neuroscience Institute, Aging Branch, Padua</wicri:regionArea>
<wicri:noRegion>Padua</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Michel, Jean Pierre" sort="Michel, Jean Pierre" uniqKey="Michel J" first="Jean-Pierre" last="Michel">Jean-Pierre Michel</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Geriatrics and Rehabilitation, Medical University of Geneva, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Geriatrics and Rehabilitation, Medical University of Geneva, Geneva</wicri:regionArea>
<orgName type="university">Université de Genève</orgName>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Prieto, Rita" sort="Prieto, Rita" uniqKey="Prieto R" first="Rita" last="Prieto">Rita Prieto</name>
<affiliation wicri:level="3"><nlm:affiliation>Pfizer GEP SLU, Upjohn, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Pfizer GEP SLU, Upjohn, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sykara, Georgia" sort="Sykara, Georgia" uniqKey="Sykara G" first="Georgia" last="Sykara">Georgia Sykara</name>
<affiliation wicri:level="3"><nlm:affiliation>Medical Affairs, Upjohn Hellas Ltd (Division of Pfizer), Athens, Greece.</nlm:affiliation>
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Medical Affairs, Upjohn Hellas Ltd (Division of Pfizer), Athens</wicri:regionArea>
<placeName><settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Donde, Shaantanu" sort="Donde, Shaantanu" uniqKey="Donde S" first="Shaantanu" last="Donde">Shaantanu Donde</name>
<affiliation wicri:level="1"><nlm:affiliation>Upjohn (Division of Pfizer), Surrey, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Upjohn (Division of Pfizer), Surrey</wicri:regionArea>
<wicri:noRegion>Surrey</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Aging clinical and experimental research</title>
<idno type="eISSN">1720-8319</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Chronic Disease (epidemiology)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (mortality)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Delivery of Health Care (MeSH)</term>
<term>Disease Outbreaks (MeSH)</term>
<term>Disease Progression (MeSH)</term>
<term>Europe (epidemiology)</term>
<term>Frail Elderly (psychology)</term>
<term>Frailty (complications)</term>
<term>Frailty (psychology)</term>
<term>Healthy Aging (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infection Control (MeSH)</term>
<term>Loneliness (MeSH)</term>
<term>Noncommunicable Diseases (epidemiology)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (mortality)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Prevalence (MeSH)</term>
<term>Quarantine (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (MeSH)</term>
<term>Europe (épidémiologie)</term>
<term>Fragilité (complications)</term>
<term>Fragilité (psychologie)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (mortalité)</term>
<term>Infections à coronavirus (prévention et contrôle)</term>
<term>Maladie chronique (épidémiologie)</term>
<term>Maladies non transmissibles (épidémiologie)</term>
<term>Pandémies (prévention et contrôle)</term>
<term>Personne âgée fragile (psychologie)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (mortalité)</term>
<term>Pneumopathie virale (prévention et contrôle)</term>
<term>Prestations des soins de santé (MeSH)</term>
<term>Prévalence (MeSH)</term>
<term>Prévention des infections (MeSH)</term>
<term>Quarantaine (MeSH)</term>
<term>Solitude (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Vieillissement  en bonne santé (MeSH)</term>
<term>Épidémies de maladies (MeSH)</term>
<term>Évolution de la maladie (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Europe</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Frailty</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Chronic Disease</term>
<term>Noncommunicable Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Fragilité</term>
<term>Personne âgée fragile</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Frail Elderly</term>
<term>Frailty</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Europe</term>
<term>Fragilité</term>
<term>Infections à coronavirus</term>
<term>Maladie chronique</term>
<term>Maladies non transmissibles</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Betacoronavirus</term>
<term>Delivery of Health Care</term>
<term>Disease Outbreaks</term>
<term>Disease Progression</term>
<term>Healthy Aging</term>
<term>Humans</term>
<term>Infection Control</term>
<term>Loneliness</term>
<term>Prevalence</term>
<term>Quarantine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term>
<term>Humains</term>
<term>Prestations des soins de santé</term>
<term>Prévalence</term>
<term>Prévention des infections</term>
<term>Quarantaine</term>
<term>Solitude</term>
<term>Sujet âgé</term>
<term>Vieillissement  en bonne santé</term>
<term>Épidémies de maladies</term>
<term>Évolution de la maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The early stages of the COVID-19 pandemic have focused on containing SARS-CoV-2 infection and identifying treatment strategies. While controlling this communicable disease is of utmost importance, the long-term effect on individuals with non-communicable diseases (NCD) is significant. Although certain NCDs appear to increase the severity of COVID-19 and mortality risk, SARS-CoV-2 infection in survivors with NCDs may also affect the progression of their pre-existing clinical conditions. Infection containment measures will have substantial short- and long-term consequences; social distancing and quarantine restrictions will reduce physical activity and increase other unhealthy lifestyles, thus increasing NCD risk factors and worsening clinical symptoms. Vitamin D levels might decrease and there might be a rise in mental health disorders. Many countries have made changes to routine management of NCD patients, e.g., cancelling non-urgent outpatient visits, which will have important implications for NCD management, diagnosis of new-onset NCDs, medication adherence, and NCD progression. We may have opportunities to learn from this unprecedented crisis on how to leverage healthcare technologies and improve procedures to optimize healthcare service provision. This article discusses how the COVID-19 outbreak and related infection control measures could hit the most frail individuals, worsening the condition of NCD patients, while further jeopardizing the sustainability of the healthcare systems. We suggest ways to define an integrated strategy that could involve both public institutional entities and the private sector to safeguard frail individuals and mitigate the impact of the outbreak.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32458356</PMID>
<DateCompleted><Year>2020</Year>
<Month>07</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1720-8319</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>32</Volume>
<Issue>7</Issue>
<PubDate><Year>2020</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Aging clinical and experimental research</Title>
<ISOAbbreviation>Aging Clin Exp Res</ISOAbbreviation>
</Journal>
<ArticleTitle>The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.</ArticleTitle>
<Pagination><MedlinePgn>1189-1194</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s40520-020-01601-4</ELocationID>
<Abstract><AbstractText>The early stages of the COVID-19 pandemic have focused on containing SARS-CoV-2 infection and identifying treatment strategies. While controlling this communicable disease is of utmost importance, the long-term effect on individuals with non-communicable diseases (NCD) is significant. Although certain NCDs appear to increase the severity of COVID-19 and mortality risk, SARS-CoV-2 infection in survivors with NCDs may also affect the progression of their pre-existing clinical conditions. Infection containment measures will have substantial short- and long-term consequences; social distancing and quarantine restrictions will reduce physical activity and increase other unhealthy lifestyles, thus increasing NCD risk factors and worsening clinical symptoms. Vitamin D levels might decrease and there might be a rise in mental health disorders. Many countries have made changes to routine management of NCD patients, e.g., cancelling non-urgent outpatient visits, which will have important implications for NCD management, diagnosis of new-onset NCDs, medication adherence, and NCD progression. We may have opportunities to learn from this unprecedented crisis on how to leverage healthcare technologies and improve procedures to optimize healthcare service provision. This article discusses how the COVID-19 outbreak and related infection control measures could hit the most frail individuals, worsening the condition of NCD patients, while further jeopardizing the sustainability of the healthcare systems. We suggest ways to define an integrated strategy that could involve both public institutional entities and the private sector to safeguard frail individuals and mitigate the impact of the outbreak.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palmer</LastName>
<ForeName>Katie</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Oliba, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Catholic University of the Sacred Heart, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Monaco</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-9941-7003</Identifier>
<AffiliationInfo><Affiliation>HEC, 1, Rue de la Liberation Jouy en Josas, Paris, France. alessandro.monaco@hec.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kivipelto</LastName>
<ForeName>Miia</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Department of NVS, Center for Alzheimer Research, Karolinska Institutet, Karolinska University Hospital, Theme Aging, Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Ageing and Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Onder</LastName>
<ForeName>Graziano</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Maggi</LastName>
<ForeName>Stefania</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>CNR-Neuroscience Institute, Aging Branch, Padua, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Michel</LastName>
<ForeName>Jean-Pierre</ForeName>
<Initials>JP</Initials>
<AffiliationInfo><Affiliation>Department of Geriatrics and Rehabilitation, Medical University of Geneva, Geneva, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Prieto</LastName>
<ForeName>Rita</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Pfizer GEP SLU, Upjohn, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sykara</LastName>
<ForeName>Georgia</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Medical Affairs, Upjohn Hellas Ltd (Division of Pfizer), Athens, Greece.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Donde</LastName>
<ForeName>Shaantanu</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Upjohn (Division of Pfizer), Surrey, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>05</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Aging Clin Exp Res</MedlineTA>
<NlmUniqueID>101132995</NlmUniqueID>
<ISSNLinking>1594-0667</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016330" MajorTopicYN="N">Frail Elderly</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="N">Frailty</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073656" MajorTopicYN="Y">Healthy Aging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008132" MajorTopicYN="N">Loneliness</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073296" MajorTopicYN="N">Noncommunicable Diseases</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Chronic diseases</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Elderly</Keyword>
<Keyword MajorTopicYN="N">Frailty</Keyword>
<Keyword MajorTopicYN="N">NCD</Keyword>
<Keyword MajorTopicYN="N">SARS-coV-2</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32458356</ArticleId>
<ArticleId IdType="doi">10.1007/s40520-020-01601-4</ArticleId>
<ArticleId IdType="pii">10.1007/s40520-020-01601-4</ArticleId>
<ArticleId IdType="pmc">PMC7248450</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>JAMA. 2020 Mar 23;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32203977</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Intern Med. 2020 Mar 13;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32167524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Alzheimers Dis. 2019;68(3):961-968</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30814346</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Med. 2013 Jul;126(7):615-24.e5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23499326</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ Open. 2017 Mar 6;7(3):e013161</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28264828</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Food Nutr Res. 2016;77:57-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26944102</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biomed Res Int. 2015;2015:217047</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26539470</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Affect Disord. 2017 Jan 15;208:56-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27750060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Soc Care Community. 2017 May;25(3):799-812</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26712585</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2020 May;26(5):976-984</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32027585</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2014 Feb 27;370(9):789-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24450860</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Psychiatry. 2020 Apr;7(4):e21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32199510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Alzheimers Dement. 2019 Mar;15(3):410-417</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30527596</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Interv Aging. 2017 May 17;12:835-845</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28553092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Affect Disord. 2019 Mar 1;246:82-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30578950</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Aging Ment Health. 2020 Feb 18;:1-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32067471</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Aging Clin Exp Res. 2019 Nov;31(11):1689-1693</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31317518</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Med Dir Assoc. 2018 Apr;19(4):355-360.e1</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29108888</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Sports Med. 2017 Dec;51(24):1750-1758</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27707740</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Mar 20;368:m1117</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32198166</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Endocrinol Metab Clin North Am. 2017 Dec;46(4):1061-1094</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29080635</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Am Geriatr Soc. 2012 Jul;60(7):1260-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22724499</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Mar 26;382(13):1268-1269</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109011</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Prev Cardiol. 2017 Jun;24(9):962-970</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28436725</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Comorb. 2019 Aug 22;9:2235042X19870934</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31489279</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Jun;92(6):577-583</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32162702</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Psychol. 2019 Sep;38(9):822-830</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31021125</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Aging Clin Exp Res. 2020 Jul;32(7):1353-1358</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32277438</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Med. 2015;47(6):474-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26340085</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Policy. 2018 Jan;122(1):4-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28967492</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Intern Med. 2018 Jun;33(6):929-935</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29374359</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
<li>Finlande</li>
<li>France</li>
<li>Grèce</li>
<li>Italie</li>
<li>Royaume-Uni</li>
<li>Suisse</li>
<li>Suède</li>
</country>
<region><li>Angleterre</li>
<li>Attique (région)</li>
<li>Canton de Genève</li>
<li>Communauté de Madrid</li>
<li>Grand Londres</li>
<li>Latium</li>
<li>Svealand</li>
<li>Île-de-France</li>
</region>
<settlement><li>Athènes</li>
<li>Genève</li>
<li>Londres</li>
<li>Madrid</li>
<li>Paris</li>
<li>Rome</li>
<li>Stockholm</li>
</settlement>
<orgName><li>Université de Genève</li>
</orgName>
</list>
<tree><country name="Italie"><region name="Latium"><name sortKey="Palmer, Katie" sort="Palmer, Katie" uniqKey="Palmer K" first="Katie" last="Palmer">Katie Palmer</name>
</region>
<name sortKey="Maggi, Stefania" sort="Maggi, Stefania" uniqKey="Maggi S" first="Stefania" last="Maggi">Stefania Maggi</name>
<name sortKey="Onder, Graziano" sort="Onder, Graziano" uniqKey="Onder G" first="Graziano" last="Onder">Graziano Onder</name>
<name sortKey="Palmer, Katie" sort="Palmer, Katie" uniqKey="Palmer K" first="Katie" last="Palmer">Katie Palmer</name>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Monaco, Alessandro" sort="Monaco, Alessandro" uniqKey="Monaco A" first="Alessandro" last="Monaco">Alessandro Monaco</name>
</region>
</country>
<country name="Suède"><region name="Svealand"><name sortKey="Kivipelto, Miia" sort="Kivipelto, Miia" uniqKey="Kivipelto M" first="Miia" last="Kivipelto">Miia Kivipelto</name>
</region>
</country>
<country name="Finlande"><noRegion><name sortKey="Kivipelto, Miia" sort="Kivipelto, Miia" uniqKey="Kivipelto M" first="Miia" last="Kivipelto">Miia Kivipelto</name>
</noRegion>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Kivipelto, Miia" sort="Kivipelto, Miia" uniqKey="Kivipelto M" first="Miia" last="Kivipelto">Miia Kivipelto</name>
</region>
<name sortKey="Donde, Shaantanu" sort="Donde, Shaantanu" uniqKey="Donde S" first="Shaantanu" last="Donde">Shaantanu Donde</name>
</country>
<country name="Suisse"><region name="Canton de Genève"><name sortKey="Michel, Jean Pierre" sort="Michel, Jean Pierre" uniqKey="Michel J" first="Jean-Pierre" last="Michel">Jean-Pierre Michel</name>
</region>
</country>
<country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Prieto, Rita" sort="Prieto, Rita" uniqKey="Prieto R" first="Rita" last="Prieto">Rita Prieto</name>
</region>
</country>
<country name="Grèce"><region name="Attique (région)"><name sortKey="Sykara, Georgia" sort="Sykara, Georgia" uniqKey="Sykara G" first="Georgia" last="Sykara">Georgia Sykara</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000401 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000401 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32458356
   |texte=   The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32458356" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021

	Serveur d'exploration sur la COVID en France
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID en France

The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.

The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki